GENOMIC REVOLUTION
MULTI-SECTOR ETF

ARKG

"Where Health Care Meets Technology"

WHY INVEST IN ARKG?

Genomic sequencing is revolutionizing how biological information is collected, processed, and applied by reducing guesswork and enhancing precision; restructuring health care, agriculture, pharmaceuticals and enhancing our quality of life.
Today, the human body can be sequenced for $1,000 in mere days. DNA sequencers can decode 235,000 human genomes in a single year, unlocking some of the secrets of life and death, making treatments more powerful, precise and profitable.1

Play Video

FUND MATERIAL

Download additional information on ARKG.
pdf_icon Fact Sheet
pdf_icon Prospectus
pdf_icon Summary Prospectus
pdf_icon Fund Holdings PDF
pdf_icon Fund Holdings CSV
pdf_iconQuarterly Report
pdf_icon Semi-Annual Report
pdf_iconAnnual Report
pdf_icon SAI
pdf_icon XBRL
pdf_iconMonth-End Performance
pdf_iconActive Share Sheet

FUND DESCRIPTION

Holdings are subject to change | As of 03/31/2018

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable:

  • Gene Therapy (21.3%)
  • Targeted Therapeutics (17.7%)
  • Beyond DNA (15.6%)
  • Bioinformatics (13.7%)
  • Instrumentation (13.5%)
  • Molecular Diagnostics (8.9%)
  • Next Generation Oncology (6.7%)
  • Stem Cells (1.7%)
  • Agricultural Biology (<1%)

ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.

FUND DETAILS

As of 03/31/2018
Ticker:ARKG
Fund Type: Active Equity ETF
CUSIP: 00214Q 302
Primary Exchange:
NYSE Arca
Inception Date:10/31/2014
Expense Ratio: 0.75%
Typical # of Holdings:30-50 Domestic Equities &
US-listed ADRs
Indicative Value: ARKG.IV
Net Asset Value (NAV):ARKG.NV
Weighted Avg. Market CAP:$31 Billion
Median Market CAP:$1 Billion
Asset Under Management$109 Million
Portfolio Managers: Catherine D. Wood

ARKG PERFORMANCE*

As of 03/31/2018
ARKG3 MonthsYTD1 YearSince Inception
(annualized)
NAV5.49%5.49%26.40%8.05%
Market Price5.14%5.14%26.18%8.10%
*Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The 
investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.

NAV AND MARKET PRICE

TOP 10 HOLDINGS

FUND COMPOSITION AND OBJECTIVE

ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

ARKG ACTIVE SHARE

As of 03/31/2018
S&P 500 INDEX MSCI WORLD INDEX
ARK GENOMIC REVOLUTION MULTI-SECTOR ETF 96% 97%
Active Share is the proportion of stock holdings in a fund’s portfolio that is different from the composition found in the benchmark.

Genomic sequencing of human DNA is projected to grow at a 200% annual growth rate.2

PREMIUM/DISCOUNT

Select time period
The Premium/Discount chart shows the difference between the daily market price of the Fund’s shares and the Fund’s net asset value (“NAV”). The daily market price is calculated using the mid-point between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund’s NAV is calculated (usually 4:00 pm Eastern time). The vertical axis of the chart shows the premium or discount of the Mid-Point price as a percentage of the NAV. The horizontal axis shows the number of trading days covered by the chart, and each bar in the chart demonstrates how many days the Fund traded within the given premium/discount range. The data presented in the chart and table above represent past performance and cannot be used to predict future results.

ARK’s thematic investing approach is based on detailed research.

Stay engaged with today’s most disruptive technologies and invest at the pace of innovation.

Explore and Read ARK Original Research

INTRADAY TRADES

ARK offers fully transparent ETFs and discloses intra-day trades for the ARKG ETF. Files of intra-day trades are not provided until full trade execution (with reasonable time to post). Click here to see intra-day trades of the current day.

DISCLOSURES

The principal risks of investing in ARK’s actively managed ETFs include equity, market, management, concentration and non-diversification risks, as well as fluctuations in market value and net asset value (“NAV”). The principal risks of investing in ARKG: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Health Care Sector Risk.
The health care sector may be adversely affected by government regulations and government health care programs. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins.

Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security.

[1] Source: ARK Investment Management LLC, Research
[2] Source: ARK Investment Management LLC, Research
  ARK ETF Webinar, Innovation ETFs, ARKQ, ARKG, ARKW, ARKK, IZRL, PRNT

Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK ETF before investing. This and other information are contained in the ARK ETFs' prospectuses, which may be obtained by clicking here. The prospectus should be read carefully before investing. An investment in an ARK ETF is subject to risks and you can lose money on your investment in an ARK ETF. There can be no assurance that the ARK ETFs will achieve their investment objectives. The ARK ETFs’ portfolios are more volatile than broad market averages. The ARK ETFs also have specific risks, which are described in the ARK ETFs' prospectuses.

Shares of the ARK ETFs may be bought or sold throughout the day at their market price on the exchange on which they are listed. The market price of an ARK ETF's shares may be at, above or below the ARK ETF’s net asset value ("NAV") and will fluctuate with changes in the NAV as well as supply and demand in the market for the shares. The market price of ARK ETF shares may differ significantly from their NAV during periods of market volatility. Shares of the ARK ETFs may only be redeemed directly with the ARK ETFs at NAV by Authorized Participants, in very large creation units. There can be no guarantee that an active trading market for ARK ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ARK ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns. Not FDIC Insured – No Bank Guarantee – May Lose Value

All statements made regarding companies, securities or other financial information on this site are strictly beliefs and points of view held by ARK Investment Management LLC and/or ARK ETF Trust and are subject to change without notice. Certain information on this site was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party. The information on this site is for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. The information on this site is general in nature and should not be considered legal or tax advice. An investor should consult a financial professional, an attorney, or tax professional regarding the investor’s specific situation.

Certain hyperlinks or referenced websites on this site may, for your convenience, forward you to third parties' websites, which generally are recognized by their top level domain name. Any descriptions of, references to, or links to other products, publications or services do not constitute an endorsement, authorization, sponsorship or affiliation with ARK with respect to any linked site or its sponsor, unless expressly stated by ARK. Any such information, products or sites have not necessarily been reviewed by ARK and are provided or maintained by third parties over whom ARK exercises no control. ARK expressly disclaims any responsibility for the content, the accuracy of the information, and/or the quality of products or services provided by or advertised on these third-party sites. ARK reserves the right to terminate any hyperlink or hyperlinking program at any time.

ARK Investment Management LLC is the investment adviser to the ARK ETFs.

Foreside Fund Services, LLC, distributor.

© 2018. ARK ETF Trust. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission.

Terms of Use
BUY ARK FUNDS